187 related articles for article (PubMed ID: 16879247)
21. The immunising effect of pneumococcal nasopharyngeal colonisation; protection against future colonisation and fatal invasive disease.
Richards L; Ferreira DM; Miyaji EN; Andrew PW; Kadioglu A
Immunobiology; 2010 Apr; 215(4):251-63. PubMed ID: 20071053
[TBL] [Abstract][Full Text] [Related]
22. Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.
Singh R; Singh S; Sharma PK; Singh UP; Briles DE; Hollingshead SK; Lillard JW
PLoS One; 2010 Feb; 5(2):e9432. PubMed ID: 20195541
[TBL] [Abstract][Full Text] [Related]
23. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP.
Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y
Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530
[TBL] [Abstract][Full Text] [Related]
24. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA).
Genschmer KR; Accavitti-Loper MA; Briles DE
Vaccine; 2013 Dec; 32(1):39-47. PubMed ID: 24211169
[TBL] [Abstract][Full Text] [Related]
25. Prediction and Validation of Immunogenic Domains of Pneumococcal Proteins Recognized by Human CD4
van de Garde MDB; van Westen E; Poelen MCM; Rots NY; van Els CACM
Infect Immun; 2019 Jun; 87(6):. PubMed ID: 30910792
[TBL] [Abstract][Full Text] [Related]
26. Immunization of aged mice with a pneumococcal conjugate vaccine combined with an unmethylated CpG-containing oligodeoxynucleotide restores defective immunoglobulin G antipolysaccharide responses and specific CD4+-T-cell priming to young adult levels.
Sen G; Chen Q; Snapper CM
Infect Immun; 2006 Apr; 74(4):2177-86. PubMed ID: 16552048
[TBL] [Abstract][Full Text] [Related]
27. Characterization of antibodies to PspA and PsaA in adults over 50 years of age with invasive pneumococcal disease.
Baril L; Briles DE; Crozier P; King J; Punar M; Hollingshead SK; McCormick JB
Vaccine; 2004 Dec; 23(6):789-93. PubMed ID: 15542203
[TBL] [Abstract][Full Text] [Related]
28. Regulation of production of mucosal antibody to pneumococcal protein antigens by T-cell-derived gamma interferon and interleukin-10 in children.
Zhang Q; Bernatoniene J; Bagrade L; Paton JC; Mitchell TJ; Hammerschmidt S; Nunez DA; Finn A
Infect Immun; 2006 Aug; 74(8):4735-43. PubMed ID: 16861661
[TBL] [Abstract][Full Text] [Related]
29. Immunization of humans with recombinant pneumococcal surface protein A (rPspA) elicits antibodies that passively protect mice from fatal infection with Streptococcus pneumoniae bearing heterologous PspA.
Briles DE; Hollingshead SK; King J; Swift A; Braun PA; Park MK; Ferguson LM; Nahm MH; Nabors GS
J Infect Dis; 2000 Dec; 182(6):1694-701. PubMed ID: 11069242
[TBL] [Abstract][Full Text] [Related]
30. The genetic background of Streptococcus pneumoniae affects protection in mice immunized with PspA.
He X; McDaniel LS
FEMS Microbiol Lett; 2007 Apr; 269(2):189-95. PubMed ID: 17355599
[TBL] [Abstract][Full Text] [Related]
31. Antibody and T-cell responses during acute and convalescent stages of invasive pneumococcal disease.
Ota MO; Oluwalana C; Howie SR; Gomez M; Ogunniyi AD; Mendy-Gomez AL; Owolabi O; Mureithi MW; Townend J; Secka O; Antonio M; Sutherland JS; Adegbola RA
Int J Infect Dis; 2011 Apr; 15(4):e282-8. PubMed ID: 21330177
[TBL] [Abstract][Full Text] [Related]
32. A nontoxic adjuvant for mucosal immunity to pneumococcal surface protein A.
Yamamoto M; Briles DE; Yamamoto S; Ohmura M; Kiyono H; McGhee JR
J Immunol; 1998 Oct; 161(8):4115-21. PubMed ID: 9780183
[TBL] [Abstract][Full Text] [Related]
33. Low CD4 T cell immunity to pneumolysin is associated with nasopharyngeal carriage of pneumococci in children.
Zhang Q; Bagrade L; Bernatoniene J; Clarke E; Paton JC; Mitchell TJ; Nunez DA; Finn A
J Infect Dis; 2007 Apr; 195(8):1194-202. PubMed ID: 17357058
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune response of a pneumococcal conjugate vaccine: capsular polysaccharide serotype 14-Lysine modified PspA.
Santamaria R; Goulart C; Perciani CT; Barazzone GC; Carvalho R; Gonçalves VM; Leite LC; Tanizaki MM
Vaccine; 2011 Nov; 29(47):8689-95. PubMed ID: 21906649
[TBL] [Abstract][Full Text] [Related]
35. Intranasal vaccination of neonatal mice with polysaccharide conjugate vaccine for protection against pneumococcal otitis media.
Sabirov A; Metzger DW
Vaccine; 2006 Jul; 24(27-28):5584-92. PubMed ID: 16730398
[TBL] [Abstract][Full Text] [Related]
36. Pneumococcal surface protein A of invasive Streptococcus pneumoniae isolates from Colombian children.
Vela Coral MC; Fonseca N; Castañeda E; Di Fabio JL; Hollingshead SK; Briles DE
Emerg Infect Dis; 2001; 7(5):832-6. PubMed ID: 11747695
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of IgG anti-capsular polysaccharide and antiprotein responses to intact Streptococcus pneumoniae in the presence of cognate CD4+ T cell help.
Khan AQ; Lees A; Snapper CM
J Immunol; 2004 Jan; 172(1):532-9. PubMed ID: 14688364
[TBL] [Abstract][Full Text] [Related]
38. Intranasal vaccination with γ-irradiated Streptococcus pneumoniae whole-cell vaccine provides serotype-independent protection mediated by B-cells and innate IL-17 responses.
Babb R; Chen A; Hirst TR; Kara EE; McColl SR; Ogunniyi AD; Paton JC; Alsharifi M
Clin Sci (Lond); 2016 May; 130(9):697-710. PubMed ID: 26831937
[TBL] [Abstract][Full Text] [Related]
39. MyD88 signaling is not essential for induction of antigen-specific B cell responses but is indispensable for protection against Streptococcus pneumoniae infection following oral vaccination with attenuated Salmonella expressing PspA antigen.
Park SM; Ko HJ; Shim DH; Yang JY; Park YH; Curtiss R; Kweon MN
J Immunol; 2008 Nov; 181(9):6447-55. PubMed ID: 18941235
[TBL] [Abstract][Full Text] [Related]
40. Immune response to capsular polysaccharide and surface proteins of Streptococcus pneumoniae in patients with invasive pneumococcal disease.
Zysk G; Bethe G; Nau R; Koch D; Gräfin Von Bassewitz VC; Heinz HP; Reinert RR
J Infect Dis; 2003 Jan; 187(2):330-3. PubMed ID: 12552461
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
